In breast cancer, this altered expression of KGF/KGFR has been extensively studied, and silencing of KGFR expression has been demonstrated to be effective in reducing cancer cells proliferation, migration and resistance to chemotherapeutic drugs [45], thus indicating that KGFR may represent an important target for the development of novel therapeutic strategies. Here, FGFR2 is linked to breast cancer.